Currently, there are limited non-invasive screening tests, such as prostate-specific antigen (PSA) tests for prostate cancer [22], colonoscopy for colorectal cancer [23], mammograms for breast cancer [24], and low-dose computed tomography (LDCT) scan for lung cancer [25]. This evidence concerns the gene KLK3 and breast cancer.